Anna MacDonald
Senior Science Editor
After obtaining a first-class honours degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.
Got a question for Anna MacDonald?
Get in touch using the contact form linked here and we’ll get back to you shortly
Published Content
Total: 311
News
First Rhinoceros Embryos Generated in the Lab
Hybrid embryos from Southern White Rhino (SWR) eggs and Northern White Rhino (NWR) sperm have been produced for the first time by adapting assisted reproduction techniques (ART) used in horses. It is hoped that the technology could be used to help efforts to save NWRs from extinction by rescuing NWR genes.
Industry Insight
Digital Pathology Solution Could Speed Up Prostate Cancer Diagnosis
To learn more about ContextVision, their move into the field of digital pathology, and how INIFY™ could help benefit pathologists and patients, we spoke to Lena Kajland Wilén, Director Business Unit Digital Pathology.
Listicle
5 Contributions HeLa Cells Have Made to Science
This list highlights five of the remarkable contributions that HeLa cells have made to science and medicine.
Infographic
Stem Cells in Regenerative Medicine
Despite its great potential, so far there has been limited success translating stem cell-based regenerative therapies into the clinic.
Article
Cell Potency: Totipotent vs Pluripotent vs Multipotent Stem Cells
Here we discuss the differences between totipotent, pluripotent, and multipotent stem cells.
Industry Insight
Accelerating the Development of Organs-on-Chips
Emulate, Inc. and AstraZeneca recently announced they have formed a collaborative partnership which will see Emulate's Organs-on-Chips technology embedded in AstraZeneca's Innovative Medicines and Early Development Biotech Unit.
Industry Insight
AI and Humans: Working Together to Improve Diagnosis
To learn more about the impact AI has already had on diagnostics and health services, as well as some of its future capabilities, we spoke to Chris Scarisbrick.
Article
Henrietta Lacks: The Mother of Modern Medicine
A portrait of Henrietta Lacks has recently been unveiled at the Smithsonian’s National Portrait Gallery, to recognize her life and the vital contributions HeLa cells have made to science.
Industry Insight
Novel Neuromuscular Junction Model Benefits Drug Discovery
The first functional stem-cell derived neuromuscular junction model has recently been licensed, which could help the quest to develop new drugs to treat associated neurodegenerative diseases. We caught up with James Hickman, CSO, Hesperos, to learn more about the model, and some of the benefits it brings.
Industry Insight
Harnessing Stem Cells for Blood Vessel Regeneration
Vascugen recently announced that it had licensed stem cell technology for blood vessel regeneration at IU School of Medicine, which could lead to new treatment options for patients suffering from Peripheral Artery Disease and Critical Limb Ischemia. We caught up with Carter Cliff, CEO, Vascugen to learn more about the technology and the science behind it.
Advertisement
